Article Details
Retrieved on: 2021-06-16 22:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Reuters) – Pfizer Inc said on Wednesday its oral rheumatoid arthritis drug Xeljanz reduced death or respiratory failure in hospitalized COVID-19 ...
Article found on: whbl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here